Product
DTaP-HepB-IPV-Hib
1 clinical trial
6 indications
Indication
DiphtheriaIndication
TetanusIndication
PertussisIndication
PoliomyelitisIndication
Hepatitis BIndication
Haemophilus influenzae type b infectionClinical trial
A Single-center, Randomized, Active-controlled, Parallel-group, Double-blind, Phase I Clinical Trial to Evaluate Safety and Immunogenicity of Hexavalent Vaccine (APV006) in Healthy AdultsStatus: Not yet recruiting, Estimated PCD: 2023-10-31